-------------------------------
OMB APPROVAL
-------------------------------
OMB Number: 3235-0145
Expires: February 28, 2006
Estimated average burden
hours per response ...11
-------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1)(1)
Dynavax Technologies Corporation
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.001 par value
--------------------------------------------------------------------------------
(Title of Class of Securities)
268158102
--------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2005
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d - 1(b)
[ ] Rule 13d - 1(c)
[X] Rule 13d - 1(d)
--------------------------------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 6 pages
ITEM 1 (a). NAME OF ISSUER:
Dynavax Technologies Corporation
ITEM 1 (b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
2929 Seventh Street
Suite 100
Berkeley, CA 94710
ITEM 2 (a). NAME OF PERSONS FILING:
(1) Forward Ventures III, L.P.; (2) Forward Ventures III
Institutional Partners, L.P.; (3) Forward III Associates,
L.L.C. (the sole general partner of Forward Ventures III,
L.P. and Forward Ventures III Institutional Partners, L.P.);
(4) Forward Ventures IV, L.P.; (5) Forward Ventures IV B,
L.P.; (6) Forward IV Associates, LLC (the sole general
partner of Forward Ventures IV, L.P. and Forward Ventures IV
B, L.P.); and (7) each of Standish M. Fleming and Ivor
Royston, M.D. (the managing members of each of Forward III
Associates, L.L.C. and Forward IV Associates, LLC). The
persons named in this paragraph are referred to individually
herein as a "Reporting Person" and collectively as the
"Reporting Persons."
ITEM 2 (b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
The address of the principal business office of each of the
Reporting Persons is 9393 Towne Centre Drive, Suite 200, San
Diego, CA 92121.
ITEM 4. OWNERSHIP:
Not applicable.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
Each Reporting Person has ceased to own beneficially more
than five percent (5%) of the outstanding Common Stock of
Dynavax Technologies Corporation.
ALL OTHER ITEMS REPORTED IN THE SCHEDULE 13G DATED AS OF FEBRUARY 10, 2005 AND
FILED ON BEHALF OF THE REPORTING PERSONS WITH RESPECT TO THE COMMON STOCK OF
DYNAVAX TECHNOLOGIES CORPORATION REMAIN UNCHANGED.
Page 2 of 6 pages
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief, each
of the undersigned certifies that the information set forth in this statement is
true, complete and correct.
Date: February 13, 2006
FORWARD VENTURES III, L.P.
By: Forward III Associates, L.L.C.
By: /s/ Standish M. Fleming
---------------------------------------
Name: Standish M. Fleming
Title: Managing Member
FORWARD VENTURES III INSTITUTIONAL PARTNERS, L.P.
By: Forward III Associates, L.L.C.
By: /s/ Standish M. Fleming
---------------------------------------
Name: Standish M. Fleming
Title: Managing Member
FORWARD III ASSOCIATES, L.L.C.
By: /s/ Standish M. Fleming
---------------------------------------
Name: Standish M. Fleming
Title: Managing Member
FORWARD VENTURES IV, L.P.
By: Forward IV Associates, LLC
By: /s/ Standish M. Fleming
---------------------------------------
Name: Standish M. Fleming
Title: Managing Member
Page 3 of 6 pages
FORWARD VENTURES IV B, L.P.
By: Forward IV Associates, LLC
By: /s/ Standish M. Fleming
---------------------------------------
Name: Standish M. Fleming
Title: Managing Member
FORWARD IV ASSOCIATES, LLC
By: /s/ Standish M. Fleming
---------------------------------------
Name: Standish M. Fleming
Title: Managing Member
/s/ Standish M. Fleming
------------------------------------
Standish M. Fleming
/s/ Ivor Royston, M.D.
------------------------------------
Ivor Royston, M.D.
Page 4 of 6 pages
AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the
undersigned hereby agree that only one statement containing the information
required by Schedule 13G need be filed with respect to the ownership by each of
the undersigned of shares of stock of Dynavax Technologies Corporation.
EXECUTED on this 13th day of February, 2006.
FORWARD VENTURES III, L.P.
By: Forward III Associates, L.L.C.
By: /s/ Standish M. Fleming
---------------------------------------
Name: Standish M. Fleming
Title: Managing Member
FORWARD VENTURES III INSTITUTIONAL PARTNERS, L.P.
By: Forward III Associates, L.L.C.
By: /s/ Standish M. Fleming
---------------------------------------
Name: Standish M. Fleming
Title: Managing Member
FORWARD III ASSOCIATES, L.L.C.
By: /s/ Standish M. Fleming
---------------------------------------
Name: Standish M. Fleming
Title: Managing Member
FORWARD VENTURES IV, L.P.
By: Forward IV Associates, LLC
By: /s/ Standish M. Fleming
---------------------------------------
Name: Standish M. Fleming
Title: Managing Member
Page 5 of 6 pages
FORWARD VENTURES IV B, L.P.
By: Forward IV Associates, LLC
By: /s/ Standish M. Fleming
---------------------------------------
Name: Standish M. Fleming
Title: Managing Member
FORWARD IV ASSOCIATES, LLC
By: /s/ Standish M. Fleming
---------------------------------------
Name: Standish M. Fleming
Title: Managing Member
/s/ Standish M. Fleming
------------------------------------
Standish M. Fleming
/s/ Ivor Royston, M.D.
------------------------------------
Ivor Royston, M.D.
Page 6 of 6 pages